Hermine, Olivier

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

Gülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice

Mast cells and histamineFood Allergy and Anaphylaxis Research

Cited by 83

Midostaurin: a magic bullet that blocks mast cell expansion and activation

Valent, P., Akin, C., Hartmann, K., George, T. I., Sotlar, K., Peter, B., Gleixner, K. V., Blatt, K., Sperr, W. R., Manley, P. W., et al. (2017) · Annals of Oncology

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 79

Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

Vermersch, P., Brieva-Ruiz, L., Fox, R. J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O., Maciejowski, M., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 74

Current concepts regarding the HTLV-1 receptor complex

Ghez, D., Lepelletier, Y., Jones, K. S., Pique, C., & Hermine, O. (2010) · Retrovirology

T-cell and Retrovirus StudiesHIV Research and Treatment

Cited by 73

Personalized management strategies in mast cell disorders: ECNM-AIM user’s guide for daily clinical practice

Valent, P., Hartmann, K., Schwaab, J., Alvarez-Twose, I., Brockow, K., Bonadonna, P., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 72

Mogamulizumab versus investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma

Phillips, A. A., Fields, P. A., Hermine, O., Ramos, J. C., Beltran, B. E., Pereira, J., Wandroo, F., Feldman, T., Taylor, G. P., Sawas, A., et al. (2019) · Haematologica

T-cell and Retrovirus StudiesCutaneous lymphoproliferative disorders research

Cited by 70

Omalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS

Lemal, R., Fouquet, G., Terriou, L., Vaes, M., Livideanu, C. B., Frenzel, L., Barete, S., Canioni, D., Lhermitte, L., Rossignol, J., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice

Mast cells and histamineFood Allergy and Anaphylaxis Research

Cited by 70

Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

Zanotti, R., Bonifacio, M., Lucchini, G., Sperr, W. R., Scaffidi, L., van Anrooij, B., Oude Elberink, H. N., Rossignol, J., Hermine, O., Gorska, A., et al. (2022) · Leukemia

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 56

Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia

Ladroue, C., Hoogewijs, D., Gad, S., Carcenac, R., Storti, F., Barrois, M., Gimenez-Roqueplo, A.-P., Leporrier, M., Casadevall, N., Hermine, O., et al. (2012) · Haematologica

Erythropoietin and Anemia TreatmentCancer, Hypoxia, and Metabolism

Cited by 55

Iron-deficiency anemia in Castleman disease: implication of the interleukin 6/hepcidin pathway

Arlet, J.-B., Hermine, O., Darnige, L., Ostland, V., Westerman, M., Badoual, C., Pouchot, J., & Capron, L. (2010) · PEDIATRICS

Iron Metabolism and DisordersTrace Elements in Health

Cited by 46

Prevalence and risk factors for fragility fracture in systemic mastocytosis

Degboé, Y., Eischen, M., Nigon, D., Apoil, P.-A., Mailhol, C., Tournier, E., Laurent, C., Hanssens, K., Hermine, O., Paul, C., et al. (2017) · Bone

Mast cells and histamineBone health and osteoporosis research

Cited by 44

Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-κB pathway

Kfoury, Y., Nasr, R., Hermine, O., de Thé, H., & Bazarbachi, A. (2005) · Cell Death & Differentiation

T-cell and Retrovirus StudiesNF-κB Signaling Pathways

Cited by 40

Paediatric mastocytosis: long-term follow-up of 53 patients with whole sequencing of KIT. A prospective study

Meni, C., Georgin-Lavialle, S., Le Saché de Peufeilhoux, L., Jais, J. P., Hadj-Rabia, S., Bruneau, J., Fraitag, S., Hanssens, K., Dubreuil, P., Hermine, O., et al. (2018) · British Journal of Dermatology

Mast cells and histamineHistiocytic Disorders and Treatments

Cited by 34

Primary cells from patients with adult T cell leukemia/lymphoma depend on HTLV-1 Tax expression for NF-κB activation and survival

Hleihel, R., Skayneh, H., de Thé, H., Hermine, O., & Bazarbachi, A. (2023) · Blood Cancer Journal

T-cell and Retrovirus StudiesViral-associated cancers and disorders

Cited by 31

TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3’ neo-enhancer

Smith, C., Goyal, A., Weichenhan, D., Allemand, E., Mayakonda, A., Toprak, U., Riedel, A., Balducci, E., Manojkumar, M., Pejkovska, A., et al. (2023) · Haematologica

Acute Lymphoblastic Leukemia researchGenomics and Chromatin Dynamics

Cited by 30

Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin

Fuchs, D., Kilbertus, A., Kofler, K., von Bubnoff, N., Shoumariyeh, K., Zanotti, R., Bonadonna, P., Scaffidi, L., Doubek, M., Elberink, H. O., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice

Mast cells and histamineHistiocytic Disorders and Treatments

Cited by 30

Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

Pyatilova, P., Akin, C., Alvarez-Twose, I., Arock, M., Bonadonna, P., Brockow, K., Butterfield, J. H., Broesby-Olsen, S., Carter, M. C., Castells, M., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice

Mast cells and histamineGastrointestinal Tumor Research and Treatment

Cited by 27

Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Dubois, B., López‑Arrieta, J., Lipschitz, S., Doskas, T., Spiru, L., Moroz, S., Venger, O., Vermersch, P., Moussy, A., Mansfield, C. D., et al. (2023) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 10

Modèle de coopération médico-pharmaceutique comme contributeur au succès du conditionnement de la greffe allogénique de cellules souches hématopoïétiques chez l’adulte : un regard croisé sur nos organisations

Bourget, P., Falaschi, L., Suarez, F., Galland, V., Blot, D., Trompette, C., Sibon, D., Fontbrune, F. S. D., Merlette, C., Vidal, F., et al. (2012) · Bulletin du Cancer

Hematopoietic Stem Cell TransplantationInterprofessional Education and Collaboration

Cited by 3